Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Health care pharmaceuticals

Pharmaceutical manufacturer · Multan · Pakistan

Pakistan pharmaceutical manufacturer represented in current DRAP product records and historical DRAP regulatory records.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Aug 2025Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
Multan, Punjab, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
50%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000905 Health Care Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000487 1 linked products · source seen 23 Sep 2026 View source ↗
DML 000905 82 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx84public portfolio records represented
REG60unique registrations represented
IDX83indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR82current validated price records
G28generic molecules in indexed catalogue
DF11dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage98%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixHealth care pharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/health-care-pharmaceuticalsGenerated 23 Sep 2026Anti-infectives50 · 60%Pain & musculoskeletal13 · 16%Vitamins, minerals & nutrition7 · 8%Gastrointestinal & hepatology7 · 8%Hematology & thrombosis2 · 2%Anesthesia & critical care2 · 2%Fluids & supportive care1 · 1%Other therapeutic areas1 · 1%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioHealth care pharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/health-care-pharmaceuticalsGenerated 23 Sep 202683presentationsSuspension24 · 29%Capsule13 · 16%Tablet13 · 16%Injection9 · 11%Cream5 · 6%Lotion5 · 6%Other forms14 · 17%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionHealth care pharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/health-care-pharmaceuticalsGenerated 23 Sep 202681comparable productsBelow peer median45 · 56%Near peer median22 · 27%Above peer median14 · 17%Company median price position-9.4%Lowest-price equivalents7Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsHealth care pharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/health-care-pharmaceuticalsGenerated 23 Sep 2026Valor Pharmaceuticals22 shared79% overlapNovaMed Pharmaceuticals(Pvt.)Ltd22 shared79% overlapMediate Pharmaceutical Pvt Ltd21 shared75% overlapGlobal Pharmaceuticals (Pvt.) Ltd.21 shared75% overlapTABROS PHARMA (PVT). LTD.21 shared75% overlapNabiqasim Industries (Pvt) Ltd.,20 shared71% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives50 products · 60%
Pain & musculoskeletal13 products · 16%
Vitamins, minerals & nutrition7 products · 8%
Gastrointestinal & hepatology7 products · 8%
Hematology & thrombosis2 products · 2%
Anesthesia & critical care2 products · 2%
Fluids & supportive care1 products · 1%
Endocrine & metabolic1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Analgesics / NSAIDs13 products · 16%
Antifungals11 products · 13%
Third-generation cephalosporins10 products · 12%
Macrolide antibacterials9 products · 11%
Fluoroquinolone antibacterials7 products · 8%
Vitamins / minerals / hematinics7 products · 8%
Proton pump inhibitors6 products · 7%
Antiseptics & disinfectants4 products · 5%
Formulation footprint

Dosage forms

Suspension24 products
Capsule13 products
Tablet13 products
Injection9 products
Cream5 products
Lotion5 products
Solution4 products
Syrup4 products
Gel3 products
Drops2 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 IbraxoneCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 ZithcarAzithromycin 7presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #3 IbuenIbuprofen 6presentations 100 mg/5 mL, 200 mg/5 mL · Suspension #4 OpaOmeprazole 6presentations 20 mg, 40 mg · Capsule #5 PractelParacetamol 6presentations 120 mg/5 mL, 250 mg/5 mL, 80 mg/0.8 mL · Suspension, Drops #6 Alafain w/v LotionTerbinafine 4presentations 1 % · Lotion
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median4556% of comparable products
Near market median22within ±5% of median
Above market median1417% of comparable products
Lowest-price equivalents7ties included
Company median price position -9.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Conacar 150 mgFluconazole · Capsule · 1’s PKR 128.70/capsule-51.3% vs market median Ayaferol-D Ayaferol-D 200000 IUCholecalciferol · Injection · 5's PKR 110.79/vial/unit-47.7% vs market median Conacar 150 mgFluconazole · Capsule · 4’s PKR 142.09/capsule-46.2% vs market median Ayaferol-D Ayaferol-D 200000 IUCholecalciferol · Injection · 1's PKR 130.48/vial/unit-35.4% vs market median P-Don Surgical Scrub 7.5 %Povidone-iodine · Surgical scrub solution · 450ml PKR 1.81/mL-30.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Valor Pharmaceuticals219 products · 97 generics 22shared generics NovaMed Pharmaceuticals(Pvt.)Ltd187 products · 62 generics 22shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 21shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 21shared generics TABROS PHARMA (PVT). LTD.179 products · 65 generics 21shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 20shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers59Distinct registrations among indexed, published, presentation-validated products only
Verified price observations83
Products with a verified price83
Products with multiple price observations0
Source records with multiple versions83
Latest portfolio source check22 Sep 2026
Latest effective price date27 Aug 2025
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

60 unique registration(s) · 83 indexed presentation(s) · 1 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Alafain w/v Lotion Terbinafine 1 % Lotion 30ml 126481 PKR 798.36 PKR 26.61/mL 9% above median
Alafain w/v Lotion Terbinafine 1 % Lotion 10ml 126481 PKR 266.12 PKR 26.61/mL 9% above median
Alafain w/v Lotion Terbinafine 1 % Lotion 20ml 126481 PKR 532.24 PKR 26.61/mL 9% above median
Alafain w/v Lotion Terbinafine 1 % Lotion 60ml 126484 PKR 1,469.36 PKR 24.49/mL 8% below median
Alafin Terbinafine 1% Cream 10gm 104591 PKR 276.27 PKR 27.63/g Near median
Alodox Doxycycline 100 mg Capsule 100’s 104515 PKR 641.37 PKR 6.41/capsule 19% below median
Alodox Doxycycline 50 mg Capsule 56’s 104520 PKR 152.30 PKR 2.72/capsule 26% below median
Ashclo Clarithromycin 125 mg/5 mL Dry suspension 60ml 104586 PKR 366.74 PKR 6.11/mL 16% below median
Ashclo Clarithromycin 250 mg/5 mL Dry suspension 60ml 104599 PKR 605.18 PKR 10.09/mL 13% below median
Ashper Permethrin 5% Cream 30gm 104590 PKR 116.98 PKR 3.90/g Near median
Ashper Permethrin 5 % Lotion 120ml 126480 PKR 314.53 PKR 2.62/mL Near median
Ayacin Ciprofloxacin 500 mg Tablet 10’s 102343 PKR 378.32 PKR 37.83/tablet 12% below median
Ayacin Ciprofloxacin 250 mg Tablet 10’s 102344 PKR 228.75 PKR 22.88/tablet 10% below median
Ayacin Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 104597 PKR 148.00 PKR 2.47/mL 30% below median
Ayacin Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 104598 PKR 263.13 PKR 4.39/mL 14% below median
Ayaferol-D Ayaferol-D Cholecalciferol 200000 IU Injection 5's 127331 PKR 553.93 PKR 110.79/vial/unit 48% below median
Ayaferol-D Ayaferol-D Cholecalciferol 200000 IU Injection 1's 127331 PKR 130.48 PKR 130.48/vial/unit 35% below median
Ayatose Iron polymaltose complex 50 mg/5 mL Syrup 60ml 102364 PKR 123.18 PKR 2.05/mL 12% below median
Ayatose Iron polymaltose complex 50 mg/5 mL Syrup 120ml 102364 PKR 212.41 PKR 1.77/mL 24% below median
Ayatose Iron + Folic acid 50 mg/5 mL + 200 mcg/5 mL Dry suspension 90ml 106381 PKR 134.85 PKR 1.50/mL No comparator
Conacar Miconazole 2 % Cream 10gm 104596 PKR 86.81 PKR 8.68/g 28% above median
Conacar Fluconazole 150 mg Capsule 4’s 106289 PKR 568.35 PKR 142.09/capsule 46% below median
Conacar Fluconazole 150 mg Capsule 1’s 106289 PKR 128.70 PKR 128.70/capsule 51% below median
Conacar Fluconazole 50 mg/5 mL Dry suspension 35ml 106380 PKR 345.35 PKR 9.87/mL 16% below median
Conacar Miconazole 2 % Gel 20gm 126479 PKR 168.24 PKR 8.41/g Near median
Conacar-V Vaginal Miconazole 2 % Vaginal cream 20gm 104595 PKR 122.98 PKR 6.15/g 21% below median
Depecar Domperidone 5 mg/5 mL Suspension 60ml 106383 PKR 72.79 PKR 1.21/mL 38% above median
Grelcar Clopidogrel 75 mg Tablet 10’s 106372 PKR 230.23 PKR 23.02/tablet 15% below median
Grelcar-DS Clopidogrel 300 mg Tablet 10’s 106373 PKR 491.92 PKR 49.19/tablet 27% below median
Ibraxone Ceftriaxone 250 mg Injection 1's 126469 PKR 198.78 PKR 198.78/vial/unit Near median
Ibraxone Ceftriaxone 250 mg Injection 1's 126470 PKR 198.78 PKR 198.78/vial/unit Near median
Ibraxone Ceftriaxone 500 mg Injection 1's 126471 PKR 334.58 PKR 334.58/vial/unit Near median
Ibraxone Ceftriaxone 500 mg Injection 1's 126472 PKR 334.58 PKR 334.58/vial/unit Near median
Ibraxone Ceftriaxone 1 g Injection 1's 126473 PKR 631.77 PKR 631.77/vial/unit 5% above median
Ibraxone Ceftriaxone 1 g Injection 1's 126474 PKR 631.77 PKR 631.77/vial/unit 5% above median
Ibraxone Ceftriaxone 2 g Injection 1's 126475 PKR 885.66 PKR 885.66/vial/unit 10% above median
Ibuen Ibuprofen 200 mg/5 mL Suspension 90ml 106384 PKR 98.67 PKR 1.10/mL 14% below median
Ibuen Ibuprofen 200 mg/5 mL Suspension 60ml 106384 PKR 65.79 PKR 1.10/mL 14% below median
Ibuen Ibuprofen 100 mg/5 mL Suspension 90ml 106385 PKR 96.84 PKR 1.08/mL 14% above median
Ibuen Ibuprofen 100 mg/5 mL Suspension 120ml 106385 PKR 129.12 PKR 1.08/mL 14% above median
Ibuen Ibuprofen 100 mg/5 mL Suspension 400ml 106385 PKR 413.19 PKR 1.03/mL 9% above median
Ibuen Ibuprofen 100 mg/5 mL Suspension 60ml 106385 PKR 64.56 PKR 1.08/mL 14% above median
Ignocar Lidocaine 2% Gel 30gm 104592 PKR 66.62 PKR 2.22/g Near median
Ignocar Lidocaine 2% Gel 15gm 104592 PKR 34.65 PKR 2.31/g Near median
Malatrin Dry Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 30ml 102356 PKR 180.61 PKR 6.02/mL Near median
Mildocin Levofloxacin 250 mg Tablet 10’s 102345 PKR 439.92 PKR 43.99/tablet 9% below median
Mildocin Levofloxacin 500 mg Tablet 10’s 102346 PKR 732.02 PKR 73.20/tablet 7% below median
Opa Omeprazole 20 mg Capsule 14’s 108426 PKR 236.81 PKR 16.92/capsule 14% below median
Opa Omeprazole 20 mg Capsule 10’s 108426 PKR 169.14 PKR 16.91/capsule 14% below median
Opa Omeprazole 20 mg Capsule 10x10’s 108426 PKR 1,428.62 PKR 14.29/capsule 27% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Health care pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/health-care-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.